Showing posts with label Delta Opioid Receptors Antibodies. Show all posts
Showing posts with label Delta Opioid Receptors Antibodies. Show all posts

Monday, February 07, 2011

More on DOR

I am always delighted when we recieve positive feedback on one of our new reagents. It is even better when a researcher graciously shares images. I would like to thank Dr. Prof. Dr. Rapheal Sell of Freie Universität Berlin for sharing these excellent Immunofluorescence images:

Images: IF detection of delta-opioid receptors in tissue engineered human oral mucosa models using Delta Opioid Receptor 361-372. The tissues were frozen at -80°C, cut into 8 µm slices and fixed with formaldehyde solution. Blocking was performed with goat serum (dilutet 1:20 in PBS) for 30 minutes at RT. Primary antibody dilutions in PBS/BSA/Tween-20 were 1:500, 1:1000 and 1:1500, slides were incubated overnight at 4°C. Secondary (fluorescent) antibody was diluted 1:400, slides were incubated for 30 minutes at room temperature in the dark. Sections were mounted with antifading mounting medium DAPI (blue) and evaluated by fluorescent microscopy

Related Reagents:
Delta Opioid Receptor 358-372
All Opioid Receptor Antibodies          
Neurotransmission Research Antibodies-GPCRs, Ligand Gated Ion Channels, Biogenic Amines and more
Primary Neurons and Astrocytes-Primary human, rat and mouse neurons and astrocytes

Thursday, December 24, 2009

Opioid Receptors and Depression

Tricyclic antidepressants (TCAs) have been reported to interact with the Opioid Receptor system, but their pharmacological activity at opioid receptors has not yet been elucidated.

We would like to share a recent publications that sheds more light on the mystery. Our purified rabbit ployclonal phosphoERK1/2 Antibody is also referenced.

Pierluigi Onali, Simona Dedoni and Maria C. Olianas. Direct Agonist Activity of Tricyclic Antidepressants at Distinct Opioid Receptor Subtypes. JPET January 2010 vol. 332 no. 1 255-265 .

At the cloned μ-opioid receptor, TCAs showed low affinity and no significant agonist activity. These results show that TCAs differentially regulate opioid receptors with a preferential agonist activity on either δ or κ subtypes and suggest that this property may contribute to their therapeutic and/or side effects.

Related Reagents:
phosphoERK1/2 (Rabbit MAb)
Immune Response Research Antibodies
Immune Response Research Proteins
Neurotrophins and Growth Factor Antibdodies
Neurotrophin Proteins
Pain and Inflammation Research Antibodies

Friday, January 23, 2009

Opioid Receptor Antibodies that Rock

We have Opioid Receptor Antibodies that work hard for our customers.

They are extensively referenced. We feature select publications and are pleased to feature the latest referencing staining of mouse neurons using our Kappa Opioid Receptor.

...Dominika Labuz, Yvonne Schmidt, Anja Schreiter, Heike L. Rittner, Shaaban A. Mousa and Halina Machelska. Immune cell–derived opioids protect against neuropathic pain in mice. J. Clin. Invest. doi:10.1172/JCI36246. Copyright © 2009, The American Society for Clinical Investigation...
...κ-opioid receptor (1:800, Neuromics)...

All Opioid Receptor Publications-Mu, Kappa and Delta

Published Reagents:
Mu Opioid Receptor-Rabbit
Mu Opioid Receptor-Guinea Pig
Delta Opioid Receptor 358-372
Kappa Opioid Receptor

Related Reagents:
Opioid Receptors
All Pain and Inflammation